Clinical Trial Update: Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study [Phase 3]

View source ↗

Summary

Clinical trial update for the Phase 3 ALTER-AD study evaluating tricaprilin in Alzheimer's disease; the trial is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Tricaprilin (tricaprilin)

Snippet

Sponsor: Cerecin | Conditions: Alzheimer Disease | Phase 3 | Status: NOT_YET_RECRUITING